Entegris

ENTG · NASDAQ

$142.90−$1.62 (−1.12%)TodayMarket closed · Oct 20, 5:08 PM ET

Prev close $144.52

ENTG analyst rating

BuyConsensus of 14 analysts over the last 12 months. 86% rate it a buy.

Strong buy0
Buy12
Hold1
Underperform0
Sell1

12-month price target · 14 analysts

Average $177.06 (+23.9% upside)

Low: $121.20
Now: $142.90
High: $225.75

Upgrades and downgrades

The latest rating actions, newest first

ENTG analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Citigroup	Oct 20, 2026	Maintains	Buy	$170.00 → $195.00	36%
Truist Securities	Oct 14, 2026	Initiates	Buy	$190.00	43%
Barclays	Oct 13, 2026	Initiates	Overweight	$212.00	50%
Stifel	Oct 8, 2026	Initiates	Buy	$200.00	69%
Deutsche Bank	Aug 12, 2026	Upgrade	Hold → Buy	$152.00 → $200.00	46%
UBS	Aug 5, 2026	Maintains	Buy	$205.00 → $215.00	69%
Oppenheimer	Aug 5, 2026	Upgrade	Perform → Outperform	$160.00 → $180.00	47%
Needham	Aug 5, 2026	Maintains	Buy	$165.00 → $170.00	100%
Deutsche Bank	Jul 6, 2026	Maintains	Hold	$145.00 → $155.00	46%
BMO Capital	Jul 6, 2026	Maintains	Outperform	$153.00 → $167.00	46%

The case for and against

Updated Oct 16, 2026

Bull case

Entegris is well positioned to outperform the semiconductor cycle because its consumable-heavy portfolio is embedded in high-value, high-risk fabrication steps where purity, defect control, and process repeatability are critical, and roughly 75% of revenue is tied to recurring production volumes while 25% is capex-linked. Exposure to leading-edge nodes, including advanced logic and memory, should lift content per wafer as AI-driven demand, 2nm transitions, HBM adoption, and higher-layer NAND architectures increase the need for filtration, CMP, deposition, and specialty chemistries. Financially, the thesis is supported by 2026E/2027E EBITDA of $1,028M/$1,243M, recent gross margin improvement, and leverage declining to 3.4x in 2Q26 with further deleveraging expected as free cash flow strengthens.

Bear case

Entegris is exposed to a highly cyclical semiconductor capital-spending environment, and its dependence on fabrication demand makes slower mainstream logic recovery, delayed capacity additions, and operational risk from new facility ramps a direct threat to growth and margins. Its top ten customers accounted for 50% of 2025 sales, while roughly 75% of revenue was weighted to Asia, including about 23% tied to Taiwan and 21% to China, leaving it vulnerable to customer concentration, export controls, tariffs, and regional demand volatility. Although its purification and wafer-handling products are mission-critical, rising competition in CMP and other materials markets could pressure share and limit the upside from the anticipated 2025 levels in EBITDA margins.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.